ASP2151, a novel helicase–primase inhibitor, possesses antiviral activity against varicella–zoster virus and herpes simplex virus types 1 and 2

著录项

• 来源
  《Journal of Antimicrobial Chemotherapy》 |2010年第8期|p.1733-1741|共9页
• 作者

  Koji Chono; Kiyomitsu Katsumata; Toru Kontani; Masayuki Kobayashi; Kenji Sudo; Tomoyuki Yokota; Kenji Konno; Yasuaki Shimizu;

  展开▼
• 作者单位

  Drug Discovery Research, Astellas Pharma Inc., Tokyo, Japan;

  Drug Discovery Research, Astellas Pharma Inc., Tokyo, Japan;

  Drug Discovery Research, Astellas Pharma Inc., Tokyo, Japan;

  Drug Discovery Research, Astellas Pharma Inc., Tokyo, Japan;

  Drug Discovery Research, Astellas Pharma Inc., Tokyo, Japan;

  Rational Drug Design Laboratories, Fukushima, Japan;

  Rational Drug Design Laboratories, Fukushima, Japan;

  Drug Discovery Research, Astellas Pharma Inc., Tokyo, Japan;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类
• 关键词